Raymond James Financial Services Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $4.27M | Buy |
109,545
+10,662
| +11% | +$416K | 0.01% | 1307 |
|
|
2024
Q2 | $3.38M | Buy |
98,883
+992
| +1% | +$33.9K | ﹤0.01% | 1369 |
|
|
2024
Q1 | $2.46M | Buy |
97,891
+37,844
| +63% | +$951K | ﹤0.01% | 1543 |
|
|
2023
Q4 | $1.77M | Buy |
60,047
+10,156
| +20% | +$300K | ﹤0.01% | 1632 |
|
|
2023
Q3 | $1.58M | Buy |
49,891
+11,862
| +31% | +$375K | ﹤0.01% | 1639 |
|
|
2023
Q2 | $984K | Sell |
38,029
-1,370
| -3% | -$35.4K | ﹤0.01% | 1932 |
|
|
2023
Q1 | $946K | Sell |
39,399
-7,853
| -17% | -$189K | ﹤0.01% | 1924 |
|
|
2022
Q4 | $921K | Sell |
47,252
-3,025
| -6% | -$59K | ﹤0.01% | 1885 |
|
|
2022
Q3 | $1.06M | Sell |
50,277
-15,542
| -24% | -$326K | ﹤0.01% | 1768 |
|
|
2022
Q2 | $1.28M | Buy |
65,819
+12,518
| +23% | +$244K | ﹤0.01% | 1682 |
|
|
2022
Q1 | $1.17M | Buy |
53,301
+27,979
| +110% | +$616K | ﹤0.01% | 1839 |
|
|
2021
Q4 | $404K | Buy |
25,322
+1,574
| +7% | +$25.1K | ﹤0.01% | 2511 |
|
|
2021
Q3 | $473K | Buy |
+23,748
| New | +$473K | ﹤0.01% | 2394 |
|